| Identification | Back Directory | [Name]
Research Grade Clivatuzumab (DHD14205) | [CAS]
1622075-09-5 | [Synonyms]
Clivatuzumab
Research Grade Clivatuzumab (DHD14205) |
| Hazard Information | Back Directory | [Uses]
Clivatuzumab is a humanized anti-mucin monoclonal antibody targeting an epitope in the MUC1 antigen expressed in most pancreatic cancers[1]. | [References]
[1] Gold DV, et al. Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucin. Mol Cancer. 2013 Nov 20;12(1):143. DOI:10.1186/1476-4598-12-143 |
|
| Company Name: |
Biolab Reagents
|
| Tel: |
027-65279366 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
Cell Sciences
|
| Tel: |
9785721070 |
| Website: |
www.cellsciences.com |
|